Viewing Study NCT06184360


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-27 @ 11:39 PM
Study NCT ID: NCT06184360
Status: COMPLETED
Last Update Posted: 2023-12-28
First Post: 2023-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module